Hans Vrielink
Papers
1
Total Citations
26
H-Index
1
About
Hans Vrielink’s research focuses on transfusion medicine and infectious disease diagnostics, with a particular emphasis on improving the safety and sensitivity of blood screening assays. His major contributions center on the early detection of hepatitis B surface antigen (HBsAg) and the identification of HBsAg mutants, which pose significant challenges to public health. In his highly cited 2001 study, Vrielink systematically compared five modern assays, demonstrating critical differences in their ability to detect both wild-type and mutant HBsAg strains. This work, which has garnered 26 citations, provided essential guidance for selecting optimal screening tools in blood banks and clinical laboratories, directly impacting the prevention of transfusion-transmitted hepatitis B. Beyond this landmark paper, Vrielink has contributed to advancing diagnostic protocols and understanding viral variants, helping to shape international standards for blood safety. His research remains a key reference for scientists and clinicians working to mitigate the risks of emerging hepatitis B mutants and enhance early detection strategies.
Research Focus
Key Achievements
Top Papers
- 1